MedPath

EVE Medical Systems Ltd.

🇮🇱Israel
Ownership
Private
Employees
-
Market Cap
-
Website

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

Phase 2
Conditions
Abortion, Recurrent
Interventions
Drug: Skin test panel
First Posted Date
2010-08-05
Last Posted Date
2010-08-05
Lead Sponsor
EVE Medical Systems Ltd.
Target Recruit Count
40
Registration Number
NCT01175759
Locations
🇭🇺

Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine, Budapest, Hungary

Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)

Phase 2
Conditions
Premenstrual Syndrome
Interventions
Drug: Skin test panel and desensitization kit
Drug: Skin test panel and solvent
First Posted Date
2009-04-01
Last Posted Date
2010-06-16
Lead Sponsor
EVE Medical Systems Ltd.
Target Recruit Count
20
Registration Number
NCT00873262
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

Phase 2
Conditions
Premenstrual Syndrome
Interventions
Drug: Skin test panel
First Posted Date
2009-03-20
Last Posted Date
2010-06-16
Lead Sponsor
EVE Medical Systems Ltd.
Target Recruit Count
40
Registration Number
NCT00866437
Locations
🇮🇱

Sheba Medical Center, Tel-Hashomer, Ramat Efal, Israel

© Copyright 2025. All Rights Reserved by MedPath